Showing results (331-340 of 981) with videos related to
Sort By:
Pageof 99
Cardiovascular Therapeutics|April 8, 2010
Surgical Maze procedure as a treatment for atrial fibrillation: a meta-analysis of randomized controlled trialsMelissa H Kong, Renato D Lopes, Jonathan P Piccini, et al.Cardiovascular Therapeutics|April 8, 2010
Chinese yellow wine and red wine inhibit matrix metalloproteinase-2 and improve atherosclerotic plaque in LDL receptor knockout miceHangyuan Guo, Longbin Liu, Yafei Shi, et al.Cardiovascular Therapeutics|March 30, 2010
New approaches to atrial fibrillation management: treat the patient, not the ECGArnold Pinter, Paul DorianCardiovascular Therapeutics|July 17, 2009
Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonistSteen Husted, J J J van GiezenCardiovascular Therapeutics|August 20, 2009
Differences in medical treatment of chronic coronary heart disease patients according to medical specialitiesAlberto Cordero, Vicente Bertomeu-Martínez, Pilar Mazón, et al.Cardiovascular Therapeutics|August 20, 2009
The effect of beta-blockers on the adaptive immune system in chronic heart failureSteven M Shaw, Teresa Coppinger, Carolyn Waywell, et al.Cardiovascular Therapeutics|March 27, 2010
Paradoxical decrease in high-density lipoprotein cholesterol with fenofibrate: a quite rare phenomenon indeedGiuliana Mombelli, Franco Pazzucconi, Alighiero Bondioli, et al.Cardiovascular Therapeutics|April 22, 2010
Proteomic mechanism of myocardial angiogenesis augmented by remote ischemic training of skeletal muscle in rabbitJing Gao, Mei Shen, Xuejiang Guo, et al.Cardiovascular Therapeutics|April 22, 2010
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque developmentAlexandros Briasoulis, Dimitris Tousoulis, Charalambos Antoniades, et al.Cardiovascular Therapeutics|April 20, 2010
Insulin signaling: a possible pathogenesis of cardiac hypertrophyWei Yu, Chunjuan Chen, Yucai Fu, et al.Pageof 99